Skip to content

The effect of Chamomile tea in dyspnea and anxiety

The effect of chamomile tea in dyspnea and anexiety on patients with chronic heart failure in the Jahrom country Honari clinic in 2014

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201308055866N11
Enrollment
60
Registered
2014-04-26
Start date
2014-04-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Dyspnea. Condition 2: Anexiety. Heart failure, unspecified Anxiety disorder, unspecified

Interventions

Intervention 1: Group intervention:The patient in interventional group in addition to standard treatment three times daily use chammomile teathat diluted one tea bag in 50cc water100degree,in order ph
Treatment - Drugs
Group intervention:The patient in interventional group in addition to standard treatment three times daily use chammomile teathat diluted one tea bag in 50cc water100degree,in order physician use in f
Control group: standard heart failure therapy, including the use Diuretic, angiotensin enzyme inhibitors, beta-blockers and anxiolytic such as diazepam and midazolam

Sponsors

Deputy of Research & Technology, Golestan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: the alert patients that can have self care; non pregnant women; can to continue treatments during 4 week; age 18 to 80 years old; dyspnea due to heart failure; have glumerular filtration rate 90-120 ml/min; without asthma or chronic obstructive pulmonary disease; without reaction to use of chamomile tea; without acute or chronic heart failure with GFR under 90 ml/min. Exclusion criteria: death; sensitivity to chamomile tea.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Degree of anexiety. Timepoint: Previous,two seconds and four seconds after intervention. Method of measurement: Beck scale.;Severity of dyspnea. Timepoint: Previous,two seconds and four seconds after intervention. Method of measurement: VAS analyse scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMassomeh Rahimi

Golestan University of Medical Sciences

rahimi.masome@gmail.com+98 17 1443 0360

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026